A detailed history of Abrdn PLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Abrdn PLC holds 255,475 shares of IDXX stock, worth $122 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
255,475
Previous 246,130 3.8%
Holding current value
$122 Million
Previous $137 Million 0.97%
% of portfolio
0.28%
Previous 0.3%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$515.08 - $576.87 $4.81 Million - $5.39 Million
9,345 Added 3.8%
255,475 $138 Million
Q4 2023

Jan 31, 2024

BUY
$391.37 - $557.56 $30.6 Million - $43.6 Million
78,166 Added 46.54%
246,130 $137 Million
Q3 2023

Nov 06, 2023

BUY
$432.42 - $556.67 $30 Million - $38.6 Million
69,343 Added 70.31%
167,964 $73.4 Million
Q2 2023

Jun 20, 2024

BUY
$450.7 - $503.61 $3.81 Million - $4.26 Million
8,458 Added 9.38%
98,621 $49.5 Million
Q2 2023

Aug 04, 2023

BUY
$450.7 - $503.61 $3.81 Million - $4.26 Million
8,458 Added 9.38%
98,621 $49.5 Million
Q1 2023

Jun 20, 2024

BUY
$406.01 - $514.59 $3.26 Million - $4.13 Million
8,023 Added 9.77%
90,163 $45.1 Million
Q1 2023

Apr 28, 2023

BUY
$406.01 - $514.59 $3.26 Million - $4.13 Million
8,023 Added 9.77%
90,163 $45.1 Million
Q4 2022

Jun 20, 2024

SELL
$324.64 - $441.27 $56.3 Million - $76.5 Million
-173,335 Reduced 67.85%
82,140 $33.5 Million
Q4 2022

Feb 09, 2023

BUY
$324.64 - $441.27 $1.85 Million - $2.52 Million
5,707 Added 7.47%
82,140 $33.5 Million
Q3 2022

Nov 10, 2022

BUY
$325.8 - $407.78 $10.9 Million - $13.6 Million
33,407 Added 77.64%
76,433 $24.9 Million
Q2 2022

Aug 05, 2022

SELL
$327.37 - $553.44 $210,498 - $355,861
-643 Reduced 1.47%
43,026 $15.1 Million
Q1 2022

May 04, 2022

BUY
$466.52 - $631.01 $338,227 - $457,482
725 Added 1.69%
43,669 $24.1 Million
Q4 2021

Feb 08, 2022

SELL
$586.54 - $666.48 $567,770 - $645,152
-968 Reduced 2.2%
42,944 $28.3 Million
Q3 2021

Nov 15, 2021

BUY
$621.9 - $705.76 $5.44 Million - $6.17 Million
8,741 Added 24.85%
43,912 $27.6 Million
Q2 2021

Aug 10, 2021

SELL
$486.36 - $637.08 $16.8 Million - $21.9 Million
-34,454 Reduced 49.49%
35,171 $22.2 Million
Q1 2021

May 06, 2021

BUY
$465.18 - $551.79 $16.1 Million - $19.1 Million
34,579 Added 98.67%
69,625 $34.1 Million
Q4 2020

Feb 10, 2021

BUY
$383.85 - $499.87 $274,068 - $356,907
714 Added 2.08%
35,046 $17.5 Million
Q3 2020

Oct 21, 2020

BUY
$334.54 - $406.31 $763,754 - $927,605
2,283 Added 7.12%
34,332 $13.5 Million
Q2 2020

Aug 10, 2020

SELL
$230.66 - $330.16 $375,283 - $537,170
-1,627 Reduced 4.83%
32,049 $10.6 Million
Q1 2020

May 13, 2020

BUY
$182.94 - $290.97 $160,804 - $255,762
879 Added 2.68%
33,676 $8.17 Million
Q4 2019

Feb 18, 2020

SELL
$248.66 - $285.01 $185,997 - $213,187
-748 Reduced 2.23%
32,797 $8.56 Million
Q3 2019

Nov 13, 2019

SELL
$260.07 - $289.93 $96,485 - $107,564
-371 Reduced 1.09%
33,545 $9.12 Million
Q2 2019

Aug 13, 2019

SELL
$215.53 - $275.33 $159,923 - $204,294
-742 Reduced 2.14%
33,916 $9.34 Million
Q1 2019

May 14, 2019

BUY
$178.02 - $225.69 $1.73 Million - $2.2 Million
9,732 Added 39.04%
34,658 $7.75 Million
Q4 2018

Feb 12, 2019

SELL
$176.18 - $248.92 $103,241 - $145,867
-586 Reduced 2.3%
24,926 $4.68 Million
Q3 2018

Nov 13, 2018

BUY
$218.82 - $254.46 $535,890 - $623,172
2,449 Added 10.62%
25,512 $6.37 Million
Q2 2018

Aug 09, 2018

BUY
$185.56 - $227.9 $1.41 Million - $1.73 Million
7,605 Added 49.2%
23,063 $5.03 Million
Q1 2018

May 15, 2018

SELL
$157.81 - $204.73 $48,605 - $63,056
-308 Reduced 1.95%
15,458 $2.96 Million
Q4 2017

Feb 12, 2018

BUY
$147.68 - $168.37 $28,502 - $32,495
193 Added 1.24%
15,766 $2.47 Million
Q3 2017

Nov 14, 2017

BUY
$150.32 - $166.46 $2.34 Million - $2.59 Million
15,573
15,573 $2.42 Million

Others Institutions Holding IDXX

About IDEXX LABORATORIES INC


  • Ticker IDXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 83,253,696
  • Market Cap $39.7B
  • Description
  • IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...
More about IDXX
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.